The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Healthcare resource utilization and costs associated with non-adherence to oral targeted therapies for patients with hematologic malignancies.
 
Krish Patel
Consulting or Advisory Role - Juno Therapeutics; Sunesis Pharmaceuticals
Speakers' Bureau - AstraZeneca; Genentech; Janssen; Pharmacyclics
Research Funding - Aptevo Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Curis (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); Takeda (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - MEI Pharma
 
Shaum Kabadi
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Vinjamuri Sai Sudhir
Employment - ZS Associates
 
Francine Leech
Employment - ZS Associates
 
Kushan Thakkar
Employment - ZS Associates
 
Joanna Huang
Employment - ZS Associates
Stock and Other Ownership Interests - Novo Nordisk
Research Funding - Novo Nordisk
Travel, Accommodations, Expenses - Novo Nordisk; ZS Associates
 
John M. Pagel
Consulting or Advisory Role - Gilead Sciences; Pharmacyclics